D. Bitar, O. Lortholary, L. Strat, and Y. , Population-based analysis of invasive fungal infections, Emerg Infect Dis, vol.20, pp.1163-1169, 2001.

Y. Suzuki, H. Kume, T. Togano, Y. Kanoh, and H. Ohto, Epidemiology of visceral mycoses in autopsy cases in Japan: the data from 1989 to 2009 in the Annual of Pathological Autopsy Cases in Japan, Med Mycol, vol.51, pp.522-526, 2013.

R. E. Lewis, L. Cahyame-zuniga, and K. Leventakos, Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study, Mycoses, vol.56, pp.638-645, 2013.

D. C. Cole, N. P. Govender, A. Chakrabarti, J. Sacarlal, and D. W. Denning, Improvement of fungal disease identification and management: combined health systems and public health approaches, Lancet Infect Dis, vol.17, pp.412-419, 2017.

, Antifungal drug maps | Gaffi -Global Action Fund for Fungal Infections, 2018.

R. Herbrecht, P. Bories, J. Moulin, M. Ledoux, and V. Letscher-bru, Risk stratification for invasive aspergillosis in immunocompromised patients: risk stratification for invasive aspergillosis, Ann N Y Acad Sci, vol.1272, pp.23-30, 2012.

O. A. Cornely, J. Maertens, and D. J. Winston, Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia, N Engl J Med, vol.356, pp.348-359, 2007.

A. J. Ullmann, J. H. Lipton, and D. H. Vesole, Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease, N Engl J Med, vol.356, pp.335-347, 2007.

F. Lamoth, S. J. Chung, L. Damonti, and A. Bd, Changing epidemiology of invasive mold infections in patients receiving azole prophylaxis, Clin Infect Dis, vol.64, pp.1619-1621, 2017.

O. Lortholary, J. Gangneux, and K. Sitbon, Epidemiological trends in invasive aspergillosis in France: the SAIF network, vol.17, pp.1882-1889, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00680990

M. C. Tisi, S. Hohaus, and A. Cuccaro, Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study, Haematologica, vol.102, pp.108-111, 2017.

M. Lugosi, C. Alberti, and J. Zahar, Aspergillus in the lower respiratory tract of immunocompetent critically ill patients, J Infect, vol.69, pp.284-292, 2014.

F. S. Taccone, A. Van-den-abeele, and P. Bulpa, Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes, Crit Care, vol.19, p.7, 2015.

K. H. Vandewoude, S. I. Blot, and P. Depuydt, Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients, Crit Care, vol.10, p.31, 2006.

T. Gustot, E. Maillart, and M. Bocci, Invasive aspergillosis in patients with severe alcoholic hepatitis, J Hepatol, vol.60, pp.267-274, 2014.

H. Prodanovic, C. Cracco, and J. Massard, Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series, BMC Gastroenterol, vol.7, issue.2, 2007.

P. G. Pappas, B. D. Alexander, and D. R. Andes, Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET), Clin Infect Dis, vol.50, pp.1101-1111, 2010.

J. Guinea, M. Torres-narbona, and P. Gijón, Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome, Clin Microbiol Infect, vol.16, pp.870-877, 2010.

N. Bakare, V. Rickerts, J. Bargon, and G. Just-nübling, Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis, Mycoses, vol.46, pp.19-23, 2003.

M. Luong, C. Chaparro, and A. Stephenson, Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis, Transplantation, vol.97, pp.351-357, 2014.

P. Rotjanapan, Y. C. Chen, and A. Chakrabarti, Epidemiology and clinical characteristics of invasive mould infections: a multicenter, retrospective analysis in five Asian countries, Med Mycol, vol.56, pp.186-196, 2018.

T. K. Kourkoumpetis, A. Desalermos, M. Muhammed, and E. Mylonakis, Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature, Medicine, vol.91, pp.328-336, 2012.

N. F. Crum-cianflone, Invasive aspergillosis associated with severe influenza infections, Open Forum Infect Dis, vol.3, p.171, 2016.

C. Garcia-vidal, P. Barba, and M. Arnan, Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients, Clin Infect Dis, vol.53, pp.16-19, 2011.

F. L. Van-de-veerdonk, E. Kolwijck, and P. Lestrade, Influenza-associated aspergillosis in critically ill patients, Am J Respir Crit Care Med, vol.196, pp.524-527, 2017.

D. W. Denning, S. E. Follansbee, M. Scolaro, S. Norris, H. Edelstein et al., Pulmonary aspergillosis in the acquired immunodeficiency syndrome, N Engl J Med, vol.324, pp.654-662, 1991.

O. Lortholary, M. C. Meyohas, and B. Dupont, Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS, Am J Med, vol.95, pp.177-187, 1993.

B. Denis, M. Guiguet, and N. De-castro, Relevance of EORTC criteria for the diagnosis of invasive aspergillosis in HIV-infected patients, and survival trends over a 20-year period in France, Clin Infect Dis, vol.61, pp.1273-1280, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01225497

B. E. Marciano, C. Spalding, and A. Fitzgerald, Common severe infections in chronic granulomatous disease, Clin Infect Dis, vol.60, pp.1176-1183, 2015.

B. Dunogué, B. Pilmis, and N. Mahlaoui, Chronic granulomatous disease in patients reaching adulthood: a nationwide study in France, Clin Infect Dis, vol.64, pp.767-775, 2017.

R. P. Gazendam, J. L. Van-hamme, and A. Tool, Human neutrophils use different mechanisms to kill Aspergillus fumigatus conidia and hyphae: evidence from phagocyte defects, J Immunol, vol.196, pp.1272-1283, 2016.

B. H. Segal, E. S. Decarlo, K. J. Kwon-chung, H. L. Malech, J. I. Gallin et al., Aspergillus nidulans infection in chronic granulomatous disease, Medicine, vol.77, pp.345-354, 1998.

F. Lanternier, S. Pathan, and Q. B. Vincent, Deep dermatophytosis and inherited CARD9 deficiency, N Engl J Med, vol.369, pp.1704-1714, 2013.

N. Rieber, R. P. Gazendam, and A. F. Freeman, ExtrapulmonaryAspergillusinfection in patients with CARD9 deficiency, JCI Insight, vol.1, p.89890, 2016.

R. P. Gazendam, J. L. Van-hamme, and A. Tool, Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects, Blood, vol.124, pp.590-597, 2014.

M. Chandesris, I. Melki, and N. A. , Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey, Medicine, vol.91, pp.1-19, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00717018

D. C. Vinh, J. A. Sugui, A. P. Hsu, A. F. Freeman, and S. M. Holland, Invasive fungal disease in autosomal-dominant hyper-IgE syndrome, J Allergy Clin Immunol, vol.125, pp.1389-1390, 2010.

T. M. Eppinger, P. A. Greenberger, D. A. White, A. E. Brown, and C. Cunningham-rundles, Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome, J Allergy Clin Immunol, vol.104, pp.1265-1272, 1999.

A. F. Freeman, D. E. Kleiner, and H. Nadiminti, Causes of death in hyper-IgE syndrome, J Allergy Clin Immunol, vol.119, pp.1234-1240, 2007.

A. Duréault, C. Tcherakian, S. Poiree, and E. A. Catherinot, Aspergillus spp. infections in STAT3 deficient patients: a nationwide study in France, 7th Advances Against Aspergillosis, 2016.

M. S. Lionakis, Genetic susceptibility to fungal infections in humans, Curr Fungal Infect Rep, vol.6, pp.11-22, 2012.

F. Lanternier, S. Cypowyj, and C. Picard, Primary immunodeficiencies underlying fungal infections, Curr Opin Pediatr, vol.25, pp.736-747, 2013.

D. Salmon-ceron, F. Tubach, and O. Lortholary, Drug-specific risk of nontuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry, Ann Rheum Dis, vol.70, pp.616-623, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00875446

D. Ghez, A. Calleja, and C. Protin, Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib, Blood, vol.131, pp.1955-1959, 2018.

T. Varughese, Y. Taur, and N. Cohen, Serious infections in patients receiving ibrutinib for treatment of lymphoid malignancies, Clin Infect Dis, vol.67, pp.687-692, 2018.

M. Baron, J. M. Zini, C. Belval, and T. , Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis, Leuk Lymphoma, vol.58, pp.2981-2982, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01851918

D. Castillo, M. Romero, F. A. Argüello, E. Kyi, C. Postow et al., The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma, Clin Infect Dis, vol.63, pp.1490-1493, 2016.

C. Kyi, M. D. Hellmann, J. D. Wolchok, P. B. Chapman, and M. A. Postow, Opportunistic infections in patients treated with immunotherapy for cancer, J Immunother Cancer, vol.2, p.19, 2014.

R. E. Greene, H. T. Schlamm, and J. Oestmann, Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign, Clin Infect Dis, vol.44, pp.373-379, 2007.

D. Caillot, J. F. Couaillier, and A. Bernard, Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia, J Clin Oncol, vol.19, pp.253-259, 2001.

C. Legouge, D. Caillot, and M. Chretien, The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?, Clin Infect Dis, vol.58, pp.672-678, 2014.

H. Wahba, M. T. Truong, X. Lei, D. P. Kontoyiannis, and E. M. Marom, Reversed halo sign in invasive pulmonary fungal kinfections, Clin Infect Dis, vol.46, pp.1733-1737, 2008.

A. Bergeron, R. Porcher, and A. Sulahian, The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies, Blood, vol.119, pp.1831-1837, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00818508

G. Marzolf, M. Sabou, and B. Lannes, Magnetic resonance imaging of cerebral aspergillosis: imaging and pathological correlations, PLOS ONE, vol.11, p.152475, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01377871

H. Mouas, I. Lutsar, and B. Dupont, Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases, Clin Infect Dis, vol.40, pp.1141-1147, 2005.

M. N. Gamaletsou, B. Rammaert, and M. A. Bueno, Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome, J Infect, vol.68, pp.478-493, 2014.

M. N. Gamaletsou, B. Rammaert, and M. A. Bueno, Aspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases, Med Mycol, vol.55, pp.246-254, 2017.

L. Moing, V. Lortholary, O. Timsit, and J. F. , Aspergillus pericarditis with tamponade: report of a successfully treated case and review, Clin Infect Dis, vol.26, pp.451-460, 1998.

S. El-ghannudi, A. Imperiale, and T. Dégot, Multimodality diagnosis approach of cardiac aspergillosis, Echocardiogr Mt Kisco N, vol.33, pp.663-665, 2016.

S. Rivière, O. Lortholary, and J. Michon, Aspergillus endocarditis in the era of new antifungals: major role for antigen detection, J Infect, vol.67, pp.85-88, 2013.

A. Gafter-gvili, M. Paul, and H. Bernstine, The role of 18 F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia, Leuk Res, vol.37, pp.1057-1062, 2013.

G. Chamilos, H. A. Macapinlac, and D. P. Kontoyiannis, The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections, Med Mycol, vol.46, pp.23-29, 2008.

A. Hot, C. Maunoury, and S. Poiree, Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections, Clin Microbiol Infect, vol.17, pp.409-417, 2011.

D. Caillot, L. Mannone, B. Cuisenier, and J. F. Couaillier, Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients, Clin Microbiol Infect, vol.7, pp.54-61, 2001.

D. Caillot, O. Casasnovas, and A. Bernard, Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery, J Clin Oncol, vol.15, pp.139-147, 1997.

T. F. Patterson, G. R. Thompson, and D. W. Denning, Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clin Infect Dis, vol.63, pp.1-60, 2016.

A. J. Ullmann, J. M. Aguado, and S. Arikan-akdagli, Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline, Clin Microbiol Infect, vol.24, pp.1-38, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01953645

C. Cordonnier, C. Pautas, and M. S. , Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial, Clin Infect Dis, vol.48, pp.1042-1051, 2009.

C. O. Morrissey, S. Chen, and T. C. Sorrell, Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial, Lancet Infect Dis, vol.13, pp.519-528, 2013.

J. R. Wingard, S. L. Carter, and T. J. Walsh, Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation, Blood, vol.116, pp.5111-5118, 2010.

D. I. Marks, A. Pagliuca, and C. C. Kibbler, Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation, Br J Haematol, vol.155, pp.318-327, 2011.

J. Van-der-linden, M. C. Arendrup, and A. Warris, Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus, Emerg Infect Dis, vol.21, pp.1041-1044, 2015.

C. Lass-florl, G. Resch, and D. Nachbaur, The value of computed tomographyguided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients, Clin Infect Dis, vol.45, pp.101-104, 2007.

C. Bernardeschi, F. Foulet, and S. Ingen-housz-oro, Cutaneous invasive aspergillosis: retrospective multicenter study of the French invasive-aspergillosis registry and literature review, Medicine, vol.94, p.1018, 2015.

S. Guégan, F. Lanternier, C. Rouzaud, N. Dupin, and O. Lortholary, Fungal skin and soft tissue infections, Curr Opin Infect Dis, vol.29, pp.124-130, 2016.

J. Maertens, V. Maertens, and K. Theunissen, Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases, Clin Infect Dis, vol.49, pp.1688-1693, 2009.

S. Schelenz, R. A. Barnes, and R. C. Barton, British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases, Lancet Infect Dis, vol.15, pp.461-474, 2015.

J. Guarner and M. E. Brandt, Histopathologic diagnosis of fungal infections in the 21st century, Clin Microbiol Rev, vol.24, pp.247-280, 2011.

M. Reinwald, B. Spiess, and W. J. Heinz, Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive aspergillosis enhances diagnostic capabilities, J Clin Microbiol, vol.51, pp.4178-4185, 2013.

P. J. Paterson, S. Seaton, and T. D. Mchugh, Validation and clinical application of molecular methods for the identification of molds in tissue, Clin Infect Dis, vol.42, pp.51-56, 2006.

C. D. Pfeiffer, J. P. Fine, and N. Safdar, Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis, Clin Infect Dis, vol.42, pp.1417-1727, 2006.

M. M. Leeflang, Y. J. Debets-ossenkopp, and C. E. Visser, Galactomannan detection for invasive aspergillosis in immunocompromized patients, Cochrane Database Syst Rev, p.7394, 2015.

L. J. Wheat and T. J. Walsh, Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay, Eur J Clin Microbiol Infect Dis, vol.27, pp.245-251, 2008.

Y. Guo, Y. Chen, K. Wang, S. Qin, C. Wu et al., Accuracy of BAL Galactomannan in diagnosing invasive aspergillosis, vol.138, pp.817-824, 2010.

J. Maertens, K. Theunissen, and G. Verhoef, Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study, Clin Infect Dis, vol.41, pp.1242-1250, 2005.

O. Marchetti, F. Lamoth, M. Mikulska, C. Viscoli, P. Verweij et al., ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients, Bone Marrow Transplant, vol.47, pp.846-854, 2012.

R. F. Duarte, I. Sánchez-ortega, and I. Cuesta, Serum galactomannanbased early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis, Clin Infect Dis, vol.59, pp.1696-1702, 2014.

K. A. Marr, M. Laverdiere, A. Gugel, and W. Leisenring, Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay, Clin Infect Dis, vol.40, pp.1762-1769, 2005.

R. F. Duarte, I. Sánchez-ortega, and M. Arnan, Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study, Bone Marrow Transplant, vol.52, pp.326-329, 2017.

F. Lamoth, M. Cruciani, and C. Mengoli, Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3), vol.54, pp.633-643, 2012.

P. L. White, J. R. Wingard, and S. Bretagne, Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing, Clin Infect Dis, vol.61, pp.1293-1303, 2015.

C. Angebault, F. Lanternier, and F. Dalle, Prospective evaluation of serum ?-glucan testing in patients with probable or proven fungal diseases, Open Forum Infect Dis, vol.3, p.128, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01518025

M. Cruciani, C. Mengoli, and J. Loeffler, Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people, Cochrane Database Syst Rev

F. Suarez, O. Lortholary, and S. Buland, Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance, J Clin Microbiol, vol.46, pp.3772-3777, 2008.

A. Alanio, J. Menotti, and M. Gits-muselli, Circulating Aspergillus fumigatus DNA is quantitatively correlated to galactomannan in serum, Front Microbiol, vol.8, p.2040, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01851829

R. Herbrecht, D. W. Denning, and T. F. Patterson, Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis, N Engl J Med, vol.347, pp.408-415, 2002.

J. Van-der-linden, E. Snelders, and G. A. Kampinga, Clinical implications of azole resistance in Aspergillus fumigatus, Emerg Infect Dis, vol.17, pp.1846-1854, 2007.

G. Chong, W. Van-de-sande, and G. Dingemans, Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid, J Clin Microbiol, vol.53, pp.868-874, 2015.

P. L. White, R. B. Posso, and R. A. Barnes, Analytical and clinical evaluation of the pathonostics AsperGenius Assay for detection of invasive aspergillosis and resistance to azole antifungal drugs during testing of serum samples, J Clin Microbiol, vol.53, pp.2115-2121, 2015.

P. L. White, R. B. Posso, and R. A. Barnes, Analytical and clinical evaluation of the pathonostics AsperGenius Assay for detection of invasive aspergillosis and resistance to azole antifungal drugs directly from plasma samples, J Clin Microbiol, vol.55, pp.2356-2366, 2017.

E. Dannaoui, F. Gabriel, and M. Gaboyard, Molecular diagnosis of invasive aspergillosis and detection of azole resistance by a newly commercialized PCR kit, J Clin Microbiol, vol.55, pp.3210-3218, 2017.

J. M. Aguado, L. Vázquez, and M. Fernández-ruiz, Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial, Clin Infect Dis, vol.60, pp.405-414, 2015.

A. Sulahian, R. Porcher, and A. Bergeron, Use and limits of (1-3)-?-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis, J Clin Microbiol, vol.52, pp.2328-2333, 2014.

P. L. White, C. Parr, C. Thornton, and R. A. Barnes, Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateralflow device for diagnosis of invasive aspergillosis, J Clin Microbiol, vol.51, pp.1510-1516, 2013.

M. G. Savelieff and L. Pappalardo, Novel cutting-edge metabolite-based diagnostic tools for aspergillosis, PLoS Pathog, vol.13, p.1006486, 2017.

B. De-pauw, T. J. Walsh, and J. P. Donnelly, Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clin Infect Dis, vol.46, pp.1813-1821, 2008.